ログイン
言語:

WEKO3

  • トップ
  • ランキング
To

Field does not validate



インデックスリンク

インデックスツリー

  • RootNode

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. センター・施設など
  2. 神経難病研究センター 神経診断治療学部門
  3. 学術雑誌掲載論文等(神経難病研究センター 神経診断治療学部門)

Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model.

http://hdl.handle.net/10422/00012786
http://hdl.handle.net/10422/00012786
f3d2c862-4bc7-4cc3-97e4-27f4d81c6faa
名前 / ファイル ライセンス アクション
fnins.2020.00845.pdf fnins.2020.00845 (4.2 MB)
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Item type 学術雑誌論文 / Journal Article(1)
公開日 2020-09-11
タイトル
タイトル Neuroprotective Effects of Casein-Derived Peptide Met-Lys-Pro (MKP) in a Hypertensive Model.
言語
言語 eng
キーワード
言語 en
主題Scheme Other
主題 brain
キーワード
言語 en
主題Scheme Other
主題 hypertension
キーワード
言語 en
主題Scheme Other
主題 ACE inhibitor
キーワード
言語 en
主題Scheme Other
主題 peptide
キーワード
言語 en
主題Scheme Other
主題 Met-Lys-Pro
キーワード
言語 en
主題Scheme Other
主題 MKP
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 TADA-MATSUZAKI, Asuka

× TADA-MATSUZAKI, Asuka

WEKO 8113

TADA-MATSUZAKI, Asuka

Search repository
HAMEZAH, Hamizah Shahirah Binti

× HAMEZAH, Hamizah Shahirah Binti

WEKO 7552

HAMEZAH, Hamizah Shahirah Binti

Search repository
YANAGISAWA, Daijiro

× YANAGISAWA, Daijiro

WEKO 7626
e-Rad 50581112

YANAGISAWA, Daijiro

Search repository
MORIKAWA, Shigehiro

× MORIKAWA, Shigehiro

WEKO 499
e-Rad 60220042

MORIKAWA, Shigehiro

Search repository
TOOYAMA, Ikuo

× TOOYAMA, Ikuo

WEKO 1957
e-Rad 20207533
ORCID 0000-0001-8054-9666

TOOYAMA, Ikuo

Search repository
著者別名 多田, 明日翔

× 多田, 明日翔

WEKO 8113

多田, 明日翔

Search repository
柳沢, 大治郎

× 柳沢, 大治郎

WEKO 7626
e-Rad 50581112

柳沢, 大治郎

Search repository
森川, 茂廣

× 森川, 茂廣

WEKO 499
e-Rad 60220042

森川, 茂廣

Search repository
遠山, 育夫

× 遠山, 育夫

WEKO 1957
e-Rad 20207533
ORCID 0000-0001-8054-9666

遠山, 育夫

Search repository
抄録
内容記述タイプ Abstract
内容記述 We have previously reported that casein hydrolysate, CH-3, from bovine milk and casein-derived tripeptide Met-Lys-Pro (MKP) has ACE inhibitory activity and reduces blood pressure. In this study, we investigated the therapeutic effects of MKP in a hypertensive rat model (7-week-old male SHRSP/Izm rats). For long term evaluation, rats were fed either a diet containing CH-3 or normal diet. The survival rate of SHRSP rats was significantly improved by intake of CH-3 for 181 days. For short term evaluation, rats were orally administered synthetic tripeptide MKP or distilled water for 4 weeks. MRI study demonstrated that hemorrhagic lesions were observed in two of five rats in the control group, while no hemorrhagic lesions were observed in the MKP group. Volumetric analysis using MRI revealed that MKP administration inhibited atrophy of diencephalic regions. Histological examinations revealed that hemorrhage areas and astrogliosis in the hippocampus and cerebral cortex were lower in the MKP group than in the control group. Gene expression analysis indicated that MKP administration reduced expression of genes related to cerebral circulation insufficiency such as immune responses (Cd74 and Prkcd), response to hypoxia (Ddit4, Apold1, and Prkcd), reactive oxygen species metabolic process (Ddit4 and Pdk4), and apoptotic process (Ddit4, Prkcd, and Sgk1), suggesting that MKP administration prevented cerebral ischemia associated with hypertension. In addition, some genes encoding responses to hormone stimulus (Fos, Dusp1, and Sik1) were also downregulated. Serum aldosterone and corticosterone levels were also significantly decreased following MKP administration. The present study indicates that MKP shows neuroprotective effects in SHRSP rats by regulating cerebral circulation insufficiency and corticoid levels. MKP administration may therefore be a potential therapeutic strategy for hypertensive brain diseases such as cerebrovascular disease.
書誌情報 en : Frontiers in Neuroscience

発行日 2020-08-14
出版者
出版者 Frontiers Media S.A.
ISSN
収録物識別子タイプ ISSN
収録物識別子 16624548
DOI
関連タイプ isIdenticalTo
識別子タイプ DOI
関連識別子 https://doi.org/10.3389/fnins.2020.00845
関連名称 10.3389/fnins.2020.00845
権利
権利情報 © 2020 Tada, Hamezah, Yanagisawa, Morikawa and Tooyama.
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
資源タイプ
内容記述タイプ Other
内容記述 Journal Article
戻る
0
views
See details
Views

Versions

Ver.1 2023-06-19 12:07:38.892592
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3